In a murine model of autoimmune hepatitis, hepatic IDO1 activation accelerates the Kyn pathway, which via AhR signaling attenuates Th17 differentiation, expands Tregs, and suppresses Akt phosphorylation, ultimately ameliorating liver injury (49). The gene discussed is AKT1; the disease is autoimmune hepatitis.